ABIOMED, Inc.
NASDAQ: ABMD
$381.02
+$0.00 (+0.0%)
Closing Price on January 3, 2023
ABMD Articles
While the broad markets are relatively flat for the year after a devastating October, here are the top 10 S&P 500 stocks that have weathered this storm.
Published:
Last Updated:
Wednesday was a mixed day for the broad U.S. markets. The S&P 500 and the Dow started out on a positive note but flipped the script halfway through the day. Crude oil made another small positive...
Published:
Last Updated:
Monday was a down day for the broad U.S. markets. The S&P 500 and the Dow pulled back from their all-time highs. Crude oil made a sizeable move and pushed even higher above $70. The S&P 500...
Published:
Last Updated:
Monday was a down day for the broad U.S. markets with the Nasdaq especially taking it on the chin. Crude oil pulled back in the session as well. The S&P 500 sectors were more or less split down...
Published:
Last Updated:
While the health care sector as a whole has had its ups and downs, there is no question that mergers and acquisitions can spike interest in the companies fast. Many on Wall Street feel that is...
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Bed Bath & Beyond, BlackBerry, ConocoPhillips, JPMorgan, Micron Technology, PGE and Wells Fargo.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66 and United Rentals.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include GoPro, KB Home, Rite Aid, Visa and Wynn Resorts.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include BlackBerry, BP, Camping World, Deere, GrubHub, KLA-Tencor, Teva Pharmaceutical and Zions Bancorp.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday include AMD, Panera, SeaWorld, T-Mobile, Walgreens and 8Point3.
Published:
Last Updated:
A new research report from Jefferies notes that when price momentum has been as bad as it has been recently, it tends to rebound in a big way.
Published:
Last Updated:
Jefferies searches for growth with reasonable valuations and upside potential. This week's picks are no exception to that rule.
Published:
Last Updated:
24/7 Wall St. has highlighted a few companies that missed their earnings, contrary to the trend, when they reported this past week.
Published:
Last Updated:
Abiomed reported better-than-expected fiscal second-quarter financial results before the markets opened on Thursday.
Published:
In a new report, Jefferies is out with three very good new growth stock ideas for investors. Two of the picks are aggressive biotech and medical device plays, and one a leading retailer.
Published: